These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9659970)

  • 41. Alternative treatments for Clostridium difficile disease: what really works?
    McFarland LV
    J Med Microbiol; 2005 Feb; 54(Pt 2):101-111. PubMed ID: 15673502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenges and opportunities in the management of Clostridium difficile infection.
    DuPont HL
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection.
    Varier RU; Biltaji E; Smith KJ; Roberts MS; Jensen MK; LaFleur J; Nelson RE
    Clin Microbiol Infect; 2014 Dec; 20(12):1343-51. PubMed ID: 25366338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.
    Burman LG
    Am J Gastroenterol; 2008 Aug; 103(8):2147; author reply 2147. PubMed ID: 18796117
    [No Abstract]   [Full Text] [Related]  

  • 47. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Clostridium difficile infections.
    Soriano MM; Johnson S
    Infect Dis Clin North Am; 2015 Mar; 29(1):93-108. PubMed ID: 25573676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
    Early CR; Park JM; Dorsch MP; Pogue KT; Hanigan SM
    Transpl Infect Dis; 2016 Oct; 18(5):714-720. PubMed ID: 27501504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vancomycin "telephone".
    Drekonja DM
    Clin Infect Dis; 2011 Jul; 53(2):211-2. PubMed ID: 21690636
    [No Abstract]   [Full Text] [Related]  

  • 52. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
    Wilcox MH
    Clin Infect Dis; 2014 Aug; 59(3):355-7. PubMed ID: 24799325
    [No Abstract]   [Full Text] [Related]  

  • 55. Clostridium difficile Infection and Patient-Specific Antimicrobial Resistance Testing Reveals a High Metronidazole Resistance Rate.
    Barkin JA; Sussman DA; Fifadara N; Barkin JS
    Dig Dis Sci; 2017 Apr; 62(4):1035-1042. PubMed ID: 28116592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of metronidazole-refractory Clostridium difficile enteritis with vancomycin.
    Follmar KE; Condron SA; Turner II; Nathan JD; Ludwig KA
    Surg Infect (Larchmt); 2008 Apr; 9(2):195-200. PubMed ID: 18426352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
    Siller-Ruiz M; Calvo-García N; Hernández-Egido S; María-Blázquez A; de Frutos-Serna M; García-Sánchez JE
    Rev Esp Quimioter; 2014 Jun; 27(2):122-6. PubMed ID: 24940894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [THE EPIDEMIOLOGY OF CLOSTRIDIUM DIFFICILE INFECTIONS AND ASPECTS PERTAINING TO TREATMENT WITH VANCOMYCIN AT ASSAF HAROFEH MEDICAL CENTER].
    Youngster I; Lazarovitch T; Bondorenco M; Kachlon Y; Toledano L; Mengesha B; Zaidenstein R; Daniel C; Dadon M; Marchaim D
    Harefuah; 2018 May; 157(5):305-308. PubMed ID: 29804335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis.
    Panichi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):493-4. PubMed ID: 2978388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.